Elevated C1GALT1 levels have been observed in various cancers, including hepatocellular carcinoma, colorectal cancer, breast cancer, head and neck squamous cell carcinoma, prostate cancer, and gastric cancer. This evidence concerns the gene C1GALT1 and hepatocellular carcinoma.